The US Food and Drug Administration named Dexcom as the first manufacturer selected for its Technology-Enabled Meaningful Patient Outcomes pilot on Tuesday. The programme, known as TEMPO, allows digital health devices to be offered to Medicare patients before the agency has authorised them for that use. The mechanism is enforcement discretion. Rather than granting approval, the FDA […]<br /> This story continues at The Next Web [...]
Stanley Johnson is not a fan of needles. The 67-year-old Air Force veteran has endured his fair share of pokes over the years, but when it was decided that IV infusions would be the best course of act [...]
The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinforma [...]
Current and former members of the FDA told CNN about issues with the Elsa generative AI tool unveiled by the federal agency last month. Three employees said that in practice, Elsa has hallucinated non [...]
UnitedHealth Group (UNH) shares cratered more than 13% Thursday morning after The Wall Street Journal reported that the Department of Justice is conducting a criminal investigation into the company’ [...]
Bayesian Health announced on September 2, 2026 that its FDA-cleared sepsis flagging device has been approved for a New Technology Add-on Payment, the Medicare mechanism that temporarily reimburses hos [...]
Nuance Audio, new "hearing glasses" from EssilorLuxottica, have received FDA clearance and "a CE marking under the Medical Devices regulation in the EU," making them officially rea [...]